Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
6.55
+0.50 (8.26%)
Jun 6, 2025, 1:37 PM - Market open
Emergent BioSolutions Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Emergent BioSolutions stock ranges from a low of $12 to a high of $16. The average analyst price target of $14.33 forecasts a 118.78% increase in the stock price over the next year.
Price Target: $14.33 (+118.78%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 1, 2025.
Analyst Ratings
The average analyst rating for Emergent BioSolutions stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +129.01% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +129.01% | Mar 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +129.01% | Mar 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +129.01% | Jan 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +129.01% | Jan 10, 2025 |
Financial Forecast
Revenue This Year
808.00M
from 1.04B
Decreased by -22.58%
Revenue Next Year
960.51M
from 808.00M
Increased by 18.88%
EPS This Year
0.72
from -3.60
EPS Next Year
1.54
from 0.72
Increased by 112.59%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 840.0M | 1.3B | 690.9M | ||
| Avg | 808.0M | 960.5M | 664.6M | ||
| Low | 784.0M | 692.9M | 644.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -19.5% | 55.3% | -28.1% | ||
| Avg | -22.6% | 18.9% | -30.8% | ||
| Low | -24.9% | -14.2% | -32.9% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 0.79 | 1.60 |
| Avg | 0.72 | 1.54 |
| Low | 0.67 | 1.49 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | 121.0% |
| Avg | - | 112.6% |
| Low | - | 106.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.